| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 79.544 | 81.362 | 79.503 | 88.370 | 88.755 | 66.929 | 84.000 | 104.483 | 114.021 | 120.332 |
| Total Income - EUR | 80.941 | 82.128 | 80.495 | 90.017 | 89.813 | 68.831 | 84.153 | 104.502 | 114.603 | 120.369 |
| Total Expenses - EUR | 39.621 | 45.244 | 50.705 | 57.921 | 64.039 | 54.239 | 61.087 | 73.167 | 75.733 | 86.482 |
| Gross Profit/Loss - EUR | 41.320 | 36.883 | 29.790 | 32.095 | 25.773 | 14.592 | 23.066 | 31.336 | 38.871 | 33.887 |
| Net Profit/Loss - EUR | 34.708 | 30.851 | 28.644 | 31.195 | 24.873 | 13.960 | 22.401 | 30.305 | 37.746 | 30.327 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Oculooptic Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 16.205 | 12.786 | 35.732 | 28.584 | 21.709 | 15.034 | 11.538 | 9.123 | 60.294 |
| Current Assets | 53.342 | 32.893 | 32.833 | 39.726 | 40.672 | 35.413 | 50.456 | 64.315 | 71.300 | 44.339 |
| Inventories | 11.709 | 9.688 | 8.591 | 9.763 | 9.026 | 8.127 | 10.823 | 8.844 | 7.939 | 9.669 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.971 | 13.367 |
| Cash | 41.634 | 23.205 | 24.242 | 29.963 | 31.646 | 27.286 | 39.634 | 55.471 | 59.389 | 21.303 |
| Shareholders Funds | 47.738 | 43.748 | 41.323 | 71.760 | 64.652 | 52.985 | 60.560 | 68.583 | 75.908 | 41.971 |
| Social Capital | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 5.604 | 5.349 | 4.297 | 3.698 | 4.604 | 4.137 | 4.930 | 7.270 | 4.515 | 62.662 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8699 - 8699" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Oculooptic Med Srl